微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.14% | -14.74% | 59.7% | 92/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 1.34% | -15.72% | 112.7% | 89/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.63% | -37.62% | -79% | 92/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3% | 44.23% | 19.52% | 78/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.51% | -10.99% | 57.86% | 93/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.59% | 15.22% | 57.43% | 93/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.01% | -0.98% | -51.44% | 93/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.08% | 0.48% | -26.24% | 87/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.82% | 18.99% | 104.35% | 93/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.38% | 10.4% | 35.29% | 94/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.02% | 2% | -50.72% | 91/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.07% | 23.95% | -12.66% | 96/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.37% | 5.33% | 89.6% | 91/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.25% | -37.19% | 25% | 100/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1% | 7.53% | -40.12% | 89/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.67% | 109.59% | -25.78% | 100/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.25% | 138.93% | 13.07% | 102/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.99% | 84.26% | 113.98% | 97/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.93% | 181.82% | 105.34% | 96/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -17.42% | -646.08% | -201.38% | 128/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -5.78% | -280.63% | -635.19% | 107/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.08% | -50.68% | 227.27% | 98/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.33% | -64.52% | -89.66% | 80/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.19% | -17.14% | -0.31% | 101/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 3.2% | 23.55% | 46.12% | 84/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.19% | 12.31% | 135.48% | 83/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.93% | -23.77% | -75.84% | 86/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.85% | -22.85% | 48.65% | 97/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 2.59% | -22.92% | 32.82% | 88/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.95% | -22% | 59.84% | 82/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.22% | 35.56% | -75.55% | 74/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.99% | -30.89% | 48.51% | 84/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.36% | -35.14% | 34.4% | 73/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.5% | -29.78% | 177.78% | 76/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.9% | -46.75% | -87.53% | 62/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 7.22% | -29.77% | 39.38% | 69/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 5.18% | -28.16% | 45.51% | 49/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 3.56% | -22.78% | 110.65% | 54/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.69% | -28.69% | -83.56% | 48/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 10.28% | 8.21% | 42.58% | 48/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 7.21% | -0.96% | 56.4% | 37/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 4.61% | -4.16% | 94.51% | 39/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.37% | 50.96% | -75.05% | 36/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |